UCLA AI model could improve outcomes of prostate cancer focal therapy

Fixing site reads without burning out the readers
Yunu modernizes clinical trial imaging assessment workflows

Imaging assessments are a requirement for most oncology trial endpoints. Yet, many cancer centers are still trying to support research trials with clinical care tools and ad hoc processes that are not fit-for-purpose and don’t meet the needs of sponsors or trial staff.

Jihad Obeid named assistant vice president for research at MUSC

Jihad Obeid was appointed as assistant vice president for research for AI Strategy & Research Intelligence at the Medical University of South Carolina.

December 05, 2025

Vol.51 No.44

Drugs & Targets

Université Paris-Saclay, Owkin partner to use AI co-pilot for biology research

Xavier Apolinarski (left), vice president of innovation at Université Paris-Saclay, and Eric Durand (right), chief research and technology officer at Owkin at the signing of the deal between Université Paris-Saclay and Owkin.Université Paris-Saclay and Owkin announce the signing of a memorandum of understanding to explore the potential of K Pro Free—Owkin’s AI co-pilot for biology—for use by Université Paris-Saclay.

December 05, 2025

Vol.51 No.44

In Brief

Onboard AI partners with Cedars-Sinai to scale responsible adoption of AI

Onboard AI and Cedars-Sinai will collaborate to deploy an automated, AI-native governance platform that health systems can use to streamline and strengthen the evaluation, approval, and monitoring of AI solutions.

November 21, 2025

Vol.51 No.43

In Brief

UCLA Health launches Department of Nuclear Medicine and Theranostics

UCLA Health has established the Department of Nuclear Medicine and Theranostics—the first of its kind in the United States. The new department will integrate advanced imaging and therapy, accelerate scientific discovery, and advance precision health at UCLA Health.

November 21, 2025

Vol.51 No.43